Treatment of depressive illness among children and adolescents in the United States

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 10, 2000, Pages 692-705

  Skaer, Tracy L ^a,b,c   Robison, Linda M ^a   Sclar, David A ^a,c,d   Galin, Richard S ^a,b,e  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Pullman Memorial Hospital   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Washington Institute for Mental Illness Research and Training   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressant; Children adolescents; Depression; National Ambulatory Medical Care Survey; Pharmacotherapy; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CHILD; CHILD PSYCHIATRY; CHILDHOOD DISEASE; COMORBIDITY; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL DISEASE; MENTAL HEALTH CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; UNITED STATES;

EID: 0033736415     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)80049-1     Document Type: Article

References (57)

1. Service utilization and social morbidity associated with depressive symptoms in the community
2. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression
3. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
4. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey
5. The economic burden of depression in 1990
6. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
7. Trends in the prescribing of antidepressant pharmacotherapy: Office-based visits, 1990-1995
8. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995
9. Epidemiology of childhood depressive disorders: A critical review
10. Puberty and depression: The roles of age, pubertal status, and pubertal timing
11. Depression in children and adolescents: A guide to diagnosis and treatment
12. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study
13. Depressed adolescents grown up
14. The underrecognition and undertreatment of depression: What is the breadth and depth of the problem?
15. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters
16. Cognitive and social cognitive development of depressed children and adolescents
17. A clinical psychotherapy trial for adolescent depression comparing cognitive family, and supportive therapy
18. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: A randomized trial of a group cognitive intervention
19. Interpersonal psychotherapy for depressed adolescents: A one year naturalistic follow-up study
20. Current issues in the treatment of major depression
21. Depression: Interventions and their effectiveness
22. Contemporary management of depression
23. Evolutionary trends in the pharmacotherapeutic management of depression
24. Pharmacological treatment of depression in children and adolescents
25. Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization
26. Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression
27. Economic outcomes with antidepressant pharmacotherapy: A retrospective intent-to-treat analysis
28. Economic appraisal of citalopram in the management of single-episodic depression
29. Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders
30. Critical review of tricyclic antidepressant use in children and adolescents
31. Tricyclic antidepressants in children. Is there a rationale for use?
32. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
33. Childhood and adolescent depression: A review of the past 10 years. Part II
34. Treatment of children with antidepressants: Focus on selective serotonin reuptake inhibitors
35. Clinical judgment, scientific data, and ethics: Antidepressant therapy in adolescents and children
36. Current perspectives on the pharmacotherapy of depressive disorders in children and adolescents
37. Prevalence variations in psychotropic treatment of children
38. Antidepressant prescribing practices of outpatient psychiatrists
39. Trends in prescribing of psychotropic medications to preschoolers
40. National Ambulatory Medical Care Survey: 1991 Summary
41. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey
42. The collection and processing of drug information: National Ambulatory Medical Care Survey. United States, 1980
43. Most common dermatologic problems identified by internists, 1990-1994
44. Depression in diabetes mellitus: A national survey of office-based encounters 1990-1995
45. Depression in Parkinson's disease: A national survey of office-based visits 1990-1995
46. Psychiatric co-morbidity and pharmacologic treatment patterns among patients presenting with insomnia: An assessment of national office-based encounters 1995-1996
47. What does treatment of depression really cost?